Nasopharyngeal Carcinoma by AJCC V8 Stage Clinical Trials

6 clinical trials for Nasopharyngeal Carcinoma by AJCC V8 Stage across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma — RECRUITING · PHASE2
• CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma — RECRUITING · NA
• Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma — RECRUITING · NA
• Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC — ACTIVE_NOT_RECRUITING · PHASE2
• Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients — OTHER

Refine this search